ATTD Journal Club - What Are We Missing in T1D Management? A Closer Look at Adjunctive Therapies
Free
- Length
- 1 hr
- Platform
- Zoom
- Topic
- Medical & Clinical
About this webinar
The use of GLP-1 and GIP/GLP-1 therapies in people with type 1 diabetes is rapidly evolving, particularly alongside automated insulin delivery. This journal club will critically examine the current evidence, from meta-analyses to recent clinical trials, and explore what the data mean for clinical practice.
Following the event, the on-demand recording and a CME/CPD accredited activity will be available on the ATTD Educational Portal.
Register to the portal for FREE here: https://unlok-education.com/register/
***IMPORTANT***
This webinar is supported by Novo Nordisk A/S. Please note that this activity is not available to participants from the United Kingdom due to regional restrictions. We appreciate your understanding, and we apologize for the inconvenience.
Recording, reproducing, or distributing the webinar content in any form is strictly prohibited.



